🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 1 will evaluate the safety and tolerability at different dose levels ...
Status
Recruiting
Location
Children's Hospital Los Angeles
Start Date
2020-03-12
Trial ID
NCT04094610
Treatments Being Tested
Phase 1 dose escalation will determine the first cycle dose-limiting toxici...
Status
Recruiting
Location
Local Institution - 2129
Start Date
2017-03-07
Trial ID
NCT03093116
Treatments Being Tested
This is a Phase 1 study to evaluate the potential drug-drug interaction (DD...
Status
Withdrawn
Location
Gabrail Cancer Research Center
Start Date
2024-11-15
Trial ID
NCT05828303
Treatments Being Tested
A Phase 1b/2 Study of Repotrectinib in Combination with Other Anticancer Th...
Status
Terminated
Location
Local Institution - 2101
Start Date
2021-09-23
Trial ID
NCT05071183
Treatments Being Tested
REPOSE is a phase II clinical trial exploring the safety and efficacy of re...
Status
Recruiting
Location
Medizinische Universität Graz
Start Date
2025-06-27
Trial ID
NCT06315010
Treatments Being Tested
This is a Phase I study of repotrectinib in combination with osimertinib in...
Status
Unknown
Location
Hospital Regional Universitario de Málaga
Start Date
2022-02-11
Trial ID
NCT04772235
Treatments Being Tested
This study will test the safety of the study drug, repotrectinib, in combin...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Start Date
2021-08-09
Trial ID
NCT05004116
Treatments Being Tested
This is a Phase 1 study to evaluate the effect of moderate or severe hepati...
Status
Withdrawn
Location
Gabrail Cancer Research Center
Start Date
2022-07-28
Trial ID
NCT05828277
Treatments Being Tested